[go: up one dir, main page]

EA199800046A1 - Полипептид, последовательность днк, вакцинная композиция (варианты), антитело или его фрагмент, вакцина, применения указанных полипептида, последовательности днк и антитела или его фрагмента - Google Patents

Полипептид, последовательность днк, вакцинная композиция (варианты), антитело или его фрагмент, вакцина, применения указанных полипептида, последовательности днк и антитела или его фрагмента

Info

Publication number
EA199800046A1
EA199800046A1 EA199800046A EA199800046A EA199800046A1 EA 199800046 A1 EA199800046 A1 EA 199800046A1 EA 199800046 A EA199800046 A EA 199800046A EA 199800046 A EA199800046 A EA 199800046A EA 199800046 A1 EA199800046 A1 EA 199800046A1
Authority
EA
Eurasian Patent Office
Prior art keywords
seq
polypeptide
antibody
fragment
dna sequence
Prior art date
Application number
EA199800046A
Other languages
English (en)
Russian (ru)
Inventor
Бернар Р. Бродор
Денис Мартэн
Клеман Риу
Хосе Хамел
Original Assignee
Байокем Вэксинс Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/472,534 external-priority patent/US5919620A/en
Application filed by Байокем Вэксинс Инк. filed Critical Байокем Вэксинс Инк.
Publication of EA199800046A1 publication Critical patent/EA199800046A1/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1275Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Streptococcus (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/09Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3156Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/30Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Distillation Of Fermentation Liquor, Processing Of Alcohols, Vinegar And Beer (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EA199800046A 1995-06-07 1996-05-17 Полипептид, последовательность днк, вакцинная композиция (варианты), антитело или его фрагмент, вакцина, применения указанных полипептида, последовательности днк и антитела или его фрагмента EA199800046A1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/472,534 US5919620A (en) 1995-06-07 1995-06-07 Heat shock protein HSP72 of Streptococcus pneumoniae
US180595P 1995-08-04 1995-08-04
PCT/CA1996/000322 WO1996040928A1 (en) 1995-06-07 1996-05-17 Streptococcal heat shock proteins members of the hsp70 family

Publications (1)

Publication Number Publication Date
EA199800046A1 true EA199800046A1 (ru) 1998-06-25

Family

ID=26669494

Family Applications (1)

Application Number Title Priority Date Filing Date
EA199800046A EA199800046A1 (ru) 1995-06-07 1996-05-17 Полипептид, последовательность днк, вакцинная композиция (варианты), антитело или его фрагмент, вакцина, применения указанных полипептида, последовательности днк и антитела или его фрагмента

Country Status (18)

Country Link
EP (1) EP0832238A1 (hu)
JP (1) JPH11507214A (hu)
KR (1) KR19990022742A (hu)
CN (1) CN1192241A (hu)
AP (1) AP9701163A0 (hu)
AR (1) AR003124A1 (hu)
AU (1) AU700080B2 (hu)
BR (1) BR9609399A (hu)
CA (1) CA2224015A1 (hu)
CZ (1) CZ394297A3 (hu)
EA (1) EA199800046A1 (hu)
HU (1) HUP0600442A3 (hu)
IL (1) IL118329A0 (hu)
NO (1) NO975752L (hu)
PL (1) PL323781A1 (hu)
SK (1) SK168497A3 (hu)
TR (1) TR199701537T1 (hu)
WO (1) WO1996040928A1 (hu)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69735715T2 (de) * 1996-05-01 2007-03-29 The Rockefeller University Cholin-bindendes Protein, welches als gegen Pneumokokken gerichtetes Vakzin verwendet wird
US6245335B1 (en) 1996-05-01 2001-06-12 The Rockefeller University Choline binding proteins for anti-pneumococcal vaccines
EP1042480A1 (en) * 1997-12-31 2000-10-11 Stressgen Biotechnologies Corporation Streptococcal heat shock proteins of the hsp60 family
US6497880B1 (en) 1998-12-08 2002-12-24 Stressgen Biotechnologies Corporation Heat shock genes and proteins from Neisseria meningitidis, Candida glabrata and Aspergillus fumigatus
US7128918B1 (en) 1998-12-23 2006-10-31 Id Biomedical Corporation Streptococcus antigens
EP2261358B1 (en) * 1998-12-23 2014-05-14 ID Biomedical Corporation of Quebec Novel streptococcus antigen
DE122009000054I1 (de) 1999-03-19 2009-12-31 Glaxosmithkline Biolog Sa Impfstoff gegen bakterielle antigene
US7015309B1 (en) 1999-06-23 2006-03-21 The Wistar Institute Of Anatomy And Biology Pyrrhocoricin-derived peptides, and methods of use thereof
GB9918319D0 (en) 1999-08-03 1999-10-06 Smithkline Beecham Biolog Vaccine composition
AU2005204321B2 (en) * 1999-08-19 2008-07-10 Immunobiology Limited Vaccines from Infectious Agents
GB9919734D0 (en) * 1999-08-19 1999-10-20 Colaco Camilo Vaccines from infectious agents
AU2795801A (en) * 2000-01-21 2001-07-31 Creighton University Biocidal molecules, macromolecular targets and methods of production and use
US6866855B2 (en) 2000-06-12 2005-03-15 University Of Saskatchewan Immunization of dairy cattle with GapC protein against Streptococcus infection
PT1294771E (pt) 2000-06-12 2009-01-06 Univ Saskatchewan Proteína gapc quimérica de streptococcus e sua utilização em vacinação e diagnóstico
US6833134B2 (en) 2000-06-12 2004-12-21 University Of Saskacthewan Immunization of dairy cattle with GapC protein against Streptococcus infection
GB0021757D0 (en) * 2000-09-04 2000-10-18 Colaco Camilo Vaccine against microbial pathogens
GB0022742D0 (en) 2000-09-15 2000-11-01 Smithkline Beecham Biolog Vaccine
EP1524992B1 (en) 2002-08-02 2015-03-04 GlaxoSmithKline Biologicals s.a. Vaccine compositions comprising l2 and/or l3 immunotype lipooligosaccharides from lgtb- neisseria menigitidis
AU2003287980B2 (en) 2002-11-01 2009-06-25 Glaxosmithkline Biologicals S.A. Drying process
EP1601770B1 (en) * 2003-03-04 2009-09-02 Intercell AG Streptococcus pyogenes antigens
CN1774447B (zh) * 2003-04-15 2011-04-06 英特塞尔股份公司 肺炎链球菌抗原
EP1667712B1 (en) 2003-10-02 2010-07-21 GlaxoSmithKline Biologicals S.A. B. pertussis antigens and use thereof in vaccination
GB0505996D0 (en) 2005-03-23 2005-04-27 Glaxosmithkline Biolog Sa Fermentation process
TWI457133B (zh) 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa 新穎組合物
ZA200805602B (en) 2006-01-17 2009-12-30 Arne Forsgren A novel surface exposed haemophilus influenzae protein (protein E; pE)
US20130004530A1 (en) 2010-03-10 2013-01-03 Jan Poolman Vaccine composition
GB201015132D0 (en) 2010-09-10 2010-10-27 Univ Bristol Vaccine composition
CN103146734B (zh) * 2013-03-12 2014-10-01 中国人民解放军军事医学科学院军事兽医研究所 抗烧烫伤感染多器官衰竭绿脓杆菌毒素疫苗
CN104001164A (zh) * 2014-04-23 2014-08-27 杭州师范大学 一种嗜水气单胞菌热激蛋白亚单位疫苗及其制备方法
CN114805567B (zh) * 2022-06-27 2022-09-16 和元生物技术(上海)股份有限公司 识别外泌体的标志蛋白hspa1a的单克隆抗体、方法和应用
CN116258247A (zh) * 2022-12-26 2023-06-13 三峡大学 一种基于SAINet神经网络模型的电力负荷预测方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2118812T3 (es) * 1991-02-15 1998-10-01 Uab Research Foundation Gen estructural de proteina pneumococica.
IT1262896B (it) * 1992-03-06 1996-07-22 Composti coniugati formati da proteine heat shock (hsp) e oligo-poli- saccaridi, loro uso per la produzione di vaccini.

Also Published As

Publication number Publication date
AR003124A1 (es) 1998-07-08
CN1192241A (zh) 1998-09-02
BR9609399A (pt) 2001-08-28
IL118329A0 (en) 1996-09-12
JPH11507214A (ja) 1999-06-29
EP0832238A1 (en) 1998-04-01
SK168497A3 (en) 1998-07-08
AU5682896A (en) 1996-12-30
AP9701163A0 (en) 1998-01-31
PL323781A1 (en) 1998-04-27
HUP0600442A3 (en) 2007-03-28
WO1996040928A1 (en) 1996-12-19
CZ394297A3 (cs) 1998-04-15
AU700080B2 (en) 1998-12-17
TR199701537T1 (xx) 1998-03-21
NO975752D0 (no) 1997-12-05
HUP0600442A2 (en) 2006-08-28
NO975752L (no) 1998-02-06
CA2224015A1 (en) 1996-12-19
KR19990022742A (ko) 1999-03-25

Similar Documents

Publication Publication Date Title
EA199800046A1 (ru) Полипептид, последовательность днк, вакцинная композиция (варианты), антитело или его фрагмент, вакцина, применения указанных полипептида, последовательности днк и антитела или его фрагмента
Porter Chemical structure of γ-globulin and antibodies
NL930012I1 (nl) Recombinant DNA,daarmee getransformeerde gastherenen door de gastheren geproduceerde polypeptiden; werkwijzen ter bereiding daarvan;detectiewerkwijzenonder toepassing van de polypeptiden; samenstellingen en middelen die de polypeptiden bevatten; DNS sequenties
EA199700248A1 (ru) Выделенный по существу очищенный поверхностный антиген белковой природы neisseria и фрагмент этого антигена
Gallizia et al. Production of a soluble and functional recombinant streptavidin inescherichia coli
KR950032279A (ko) 인체의 프로그램된 세포 사멸과 관련 있는 펩티드 및 이를 암호하는 디엔에이(dna)
CA2289912A1 (en) Human receptor proteins; related reagents and methods
ATE365744T1 (de) Nukleinsäuremoleküle, proteine und peptide, die im zusammenhang stehen mit dickdarmzellen und dickdarm-krebszellen
HUP9802401A2 (hu) Az emberi gp39-protein különböző epitópjaira specifikus monoklonális antitestek, valamint eljárások az ilyen antitestek diagnosztikai és terápiás alkalmazására
EA199800973A1 (ru) Полипептид белка-106 наружной мембраны moraxella catarrhalis, последовательность гена и их применение
NO995689D0 (no) Forbindelser for immunoterapi og diagnose av tuberkulose og metoder for deres anvendelse
ATE301716T1 (de) Vmp-ähnliche sequenzen von pathogener borrelia
ATE135403T1 (de) Herstellung und reinigung eines proteins, das mit einem bindungsprotein fusioniert ist
RU98112759A (ru) Человеческий семафорин l (h-sema-l) и соответствующие семафорины в других видах
TR27970A (tr) Bitki kofulu icine hedeflemede kullanilan yeni sinyal dizimleri.
ATE478089T1 (de) Isolierte polypeptide auf der grundlage des neutralisierenden epitops des p17-proteins vom hiv geeignet als impfstoffe und neutralisierende anti-p17-antikörper, die besagtes epitop spezifisch erkennen
Sledge et al. Antibody structure: amino terminal sequences of nurse shark light and heavy chains
KR880003006A (ko) 리노바이러스 균주 hrv 89의 폴리펩타이드 및 이를 코드화한 dna 분자
WO1995008628A3 (en) Nucleic acids encoding merosin, merosin fragments and uses thereof
SE9704141D0 (sv) New protein and nucleotide sequence, encoding said protein
DE69629304D1 (de) Membranproteine von leptospira
MX9709557A (es) Miembros de proteinas de choque termico estreptococales de la familia hsp7o.
CA2642146A1 (en) Xrec2 dnas and polypeptides
Gorman et al. Characterisation of the third component of canine and feline complement
WO2000043419A3 (en) Exocytosis pathway proteins and methods of use